Literature DB >> 21706210

[Extramammary Paget disease: successful therapy with imiquimod 5% cream].

G Wagner1, M Heine, M M Sachse.   

Abstract

A 90-year-old woman presented with an extensive primary form of extramammary Paget disease localized in the anogenital region. An associated carcinoma could be excluded. Due to the age of the patient, the location and extent of the tumor as well as existing comorbidities, neither a surgical nor a radio-oncological treatment were advisable. A local treatment with imiquimod 5% cream applied 3 times weekly for 2 × 3 weeks led to a clinically and histopathologically complete remission. As also shown by other authors, imiquimod appears to be a treatment option for the primary form of extramammary Paget disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21706210     DOI: 10.1007/s00105-011-2203-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  28 in total

Review 1.  Treatment of primary limited cutaneous extramammary Paget's disease with topical imiquimod monotherapy: two case reports.

Authors:  Jennifer C Zampogna; Franklin P Flowers; William I Roth; Ashraf M Hassenein
Journal:  J Am Acad Dermatol       Date:  2002-10       Impact factor: 11.527

Review 2.  The role of topical immune response modifiers in skin cancer.

Authors:  Courtney Woodmansee; Jessica Pillow; Robert B Skinner
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 3.  Mammary and extramammary Paget's disease.

Authors:  J Kanitakis
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-05       Impact factor: 6.166

4.  Treatment of genital Paget's skin disease with topical imiquimod: severe adverse events.

Authors:  Laurent Misery
Journal:  J Dermatolog Treat       Date:  2007       Impact factor: 3.359

5.  Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis.

Authors:  Slawomir Majewski; Maria Marczak; Beata Mlynarczyk; Bernd Benninghoff; Stefania Jablonska
Journal:  Int J Dermatol       Date:  2005-01       Impact factor: 2.736

6.  Extramammary Paget's disease: surgical treatment with Mohs micrographic surgery.

Authors:  Ali Hendi; David G Brodland; John A Zitelli
Journal:  J Am Acad Dermatol       Date:  2004-11       Impact factor: 11.527

7.  Long-term follow-up of in situ extramammary Paget's disease in Asian skin types IV/V treated with photodynamic therapy.

Authors:  Qiang Li; Tianwen Gao; Bin Jiao; Xianlong Qi; Heather Ann Long; Hongjiang Qiao; Lei Wang; Yajie Lv; Xuehui Hu; Wenjun Liao; Shengchun Wang; Chunying Li
Journal:  Acta Derm Venereol       Date:  2010-03       Impact factor: 4.437

8.  [Topical therapy of extramammary Paget's disease].

Authors:  M Arensmeier; U Theuring; I Franke; C Willgeroth; K H Kühne
Journal:  Hautarzt       Date:  1994-11       Impact factor: 0.751

9.  [Differential diagnosis of chronic perianal dermatitis. Premalignant and malignant disorders].

Authors:  J Wacker; W Hartschuh
Journal:  Hautarzt       Date:  2004-03       Impact factor: 0.751

10.  [Topical immunomodulators in dermatology].

Authors:  N Meykadeh; U R Hengge
Journal:  Hautarzt       Date:  2003-07       Impact factor: 0.751

View more
  3 in total

1.  [64-year-old male with treatment-refractory whitish erythematous plaques on the right groin area and scrotum : Preparation for the specialist examination: part 19].

Authors:  Benjamin Thomas; Moritz Felcht
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

2.  [Extramammary Paget's disease].

Authors:  Jan Eggen; Janna Garaganova; Marco Zamperetti; Jens Wallmichrath; Tanja von Braunmühl; Thomas Herzinger
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

Review 3.  Effects of imiquimod on vulvar Paget's disease: a systematic review of literature.

Authors:  Hiroko Machida; Aida Moeini; Lynda D Roman; Koji Matsuo
Journal:  Gynecol Oncol       Date:  2015-07-17       Impact factor: 5.482

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.